this therapy is based on the concepts ( 1 ) that cancer patients have low immuno-reactivity and generalized tissue damage , especially of the liver , and ( 2 ) that when the cancer is destroyed , toxic degradation products appear in the bloodstream which lead to coma and death from liver failure .
C0023884
liver
C0085605
liver failure